Because the cancer genome usually contains both hyper- and hypomethylated genes to increase invasion, proliferation, and metastasis, epigenetic control of inflammatory genes such as COX-2 should be taken into consideration as a potential therapeutic target in tumoral pathology. Here, PTGS2 is linked to cancer.